Saskatoon, Saskatchewan — September 4, 2026 — Leads & Copy — MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) today announced the appointment of Tyler Reinheimer, CPA, as Director, Finance. The company’s board of directors has also authorized the grant of 1,126,954 deferred share units (DSUs) to directors, excluding the CEO and COO, and to Mr. Reinheimer, effective September 3, 2026. These DSUs are being granted under the Company’s omnibus equity incentive plan. The DSUs will vest when the recipient ceases to be a director, officer, or employee of MustGrow or its affiliates. Upon settlement, each DSU will entitle the holder to receive one common share of the Company or a cash payment equivalent, at the Company’s discretion.
MustGrow Biologics Corp. is a provider of biological and regenerative agriculture solutions aimed at supporting sustainable farming practices. The Company’s technology leverages natural defense mechanisms and organic compounds found in mustard seeds, which are formulated into organic biofertility, biostimulant, and biocontrol products. These offerings are designed to enhance soil health, support plant vitality, and contribute to global food security through more sustainable agricultural methods.
In the United States, MustGrow’s flagship biofertility product, TerraSanteTM, is registered, organically certified, and commercially available in key agricultural states, including California. Outside of North America, MustGrow is collaborating with major global agriculture companies, such as Bayer AG in Europe, the Middle East, and Africa, to commercialize its proprietary products and technologies. The Company is focused on increasing shareholder value by expanding its intellectual property portfolio, which includes approximately 110 issued and pending patents.
MustGrow is publicly traded on the TSX Venture Exchange under the symbol MGRO. The company has approximately 70.4 million common shares issued and outstanding, with approximately 93.0 million shares on a fully diluted basis.
Source: MustGrow Biologics Corp.
